# Topical 15% Trichloroacetic Acid Versus Silver Nitrate Cauterization in the Management of Idiopathic Childhood Epistaxis: A Prospective Double-Blinded, Randomized Clinical Trial

> **NCT06836791** · NA · COMPLETED · sponsor: **Youssef Zaki** · enrollment: 170 (actual)

## Conditions studied

- Anterior Epistaxis

## Interventions

- **PROCEDURE:** chemical cautrizating agents to stop epistaxis
- **DRUG:** Silver Nitrate
- **DRUG:** Trichloroacetic Acid Topical

## Key facts

- **NCT ID:** NCT06836791
- **Lead sponsor:** Youssef Zaki
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-03-01
- **Primary completion:** 2024-10-01
- **Final completion:** 2024-11-02
- **Target enrollment:** 170 (ACTUAL)
- **Last updated:** 2025-02-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06836791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06836791, "Topical 15% Trichloroacetic Acid Versus Silver Nitrate Cauterization in the Management of Idiopathic Childhood Epistaxis: A Prospective Double-Blinded, Randomized Clinical Trial". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT06836791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*